262 related articles for article (PubMed ID: 7540924)
1. Tumour markers.
Pandha HS; Waxman J
QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
[TBL] [Abstract][Full Text] [Related]
2. Tumour markers.
Pandha HS; Waxman J; Sikora K
Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers].
Cohen AD; Cohen Y
Harefuah; 1993 Oct; 125(7-8):243-6. PubMed ID: 7693557
[No Abstract] [Full Text] [Related]
4. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
5. [Use of tumor markers in patients on chronic hemodialysis].
Kuno T; Kaizu K
Nihon Rinsho; 2004 Jun; 62 Suppl 6():391-4. PubMed ID: 15250332
[No Abstract] [Full Text] [Related]
6. Non-invasive cancer detection: strategies for the identification of novel cancer markers.
Sorio C; Mauri P; Pederzoli P; Scarpa A
IUBMB Life; 2006 Apr; 58(4):193-8. PubMed ID: 16754296
[TBL] [Abstract][Full Text] [Related]
7. Use of tumour markers in cancer diagnosis and treatment.
Higgins C
Nurs Times; 1996 Apr 17-23; 92(16):36-7. PubMed ID: 8710591
[TBL] [Abstract][Full Text] [Related]
8. New frontiers in ovarian cancer diagnosis and management.
Barber HR
Yale J Biol Med; 1991; 64(2):127-41. PubMed ID: 1721478
[TBL] [Abstract][Full Text] [Related]
9. Tumor markers in urology.
Grossman HB
Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
[No Abstract] [Full Text] [Related]
10. [Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach].
Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
Wiad Lek; 1988 Jul; 41(14):915-20. PubMed ID: 2467444
[No Abstract] [Full Text] [Related]
11. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
Bellet D; Bidart JM
Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
[No Abstract] [Full Text] [Related]
12. Tumour markers in gynaecologic oncology.
Onsrud M
Scand J Clin Lab Invest Suppl; 1991; 206():60-70. PubMed ID: 1719611
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
Feintrenie X; Briancon S; Pichene M; Lamy P
Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
[TBL] [Abstract][Full Text] [Related]
14. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers in the diagnosis of lung cancer].
Marel M; Bíbrová L; Melínová L; Potocková L; Svandová E
Cas Lek Cesk; 1993 Feb; 132(4):108-12. PubMed ID: 7682476
[TBL] [Abstract][Full Text] [Related]
16. The use of serum tumor markers in the management of patients with malignancy.
Markman M
J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
[No Abstract] [Full Text] [Related]
17. [Sense and nonsense of tumor markers in practice].
Joss R; Cerny T
Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
[TBL] [Abstract][Full Text] [Related]
18. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
Fossa SD; Paus E
Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
[No Abstract] [Full Text] [Related]
19. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
[TBL] [Abstract][Full Text] [Related]
20. [Concentration of carcinoembryonic antigen, alpha-fetoprotein and beta-subunit of human chorionic gonadotropin in serum of workers employed directly in the production of coke].
Snit M
Med Pr; 1993; 44(1):21-8. PubMed ID: 7684110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
